×
Entrez Id:
2056
Gene Symbol:
EPO
EPO
0.100
AlteredExpression
disease
BEFREE
Laboratory EPO serum levels were determined, and they were correlated to the stage of DR .
31727007
2019
×
Entrez Id:
2056
Gene Symbol:
EPO
EPO
0.100
Biomarker
disease
BEFREE
The severity of diabetic retinopathy has a negative association with EPO and positive correlations with Caspase-3, NO, and MDA content.
31799636
2019
×
Entrez Id:
2056
Gene Symbol:
EPO
EPO
0.100
Biomarker
disease
BEFREE
Erythropoietin protects outer blood-retinal barrier in experimental diabetic retinopathy by up-regulating ZO-1 and occludin.
31483932
2019
×
Entrez Id:
2056
Gene Symbol:
EPO
EPO
0.100
Biomarker
disease
BEFREE
Molecular mechanism of the role of carbamyl erythropoietin in treating diabetic retinopathy rats.
29896254
2018
×
Entrez Id:
2056
Gene Symbol:
EPO
EPO
0.100
Biomarker
disease
BEFREE
In this case-control study, the erythropoietin (EPO ) promoter variant s1617640, linked to high intravitreal EPO concentrations and increased risk of diabetic retinopathy , was not associated with severe retinopathy of prematurity.
29731355
2018
×
Entrez Id:
2056
Gene Symbol:
EPO
EPO
0.100
Biomarker
disease
BEFREE
In vitro and in vivo experimental studies as well as small interventional clinical studies suggest a potential beneficial effect of externally administered EPO in early diabetic retinopathy and diabetic macular oedema.
28652140
2017
×
Entrez Id:
2056
Gene Symbol:
EPO
EPO
0.100
GeneticVariation
disease
BEFREE
Gene-gene interaction of erythropoietin gene polymorphisms and diabetic retinopathy in Chinese Han.
27190272
2016
×
Entrez Id:
2056
Gene Symbol:
EPO
EPO
0.100
GeneticVariation
disease
BEFREE
Odds ratios (ORs) for the effects of erythropoietin gene polymorphisms on DR risk.
25675872
2015
×
Entrez Id:
2056
Gene Symbol:
EPO
EPO
0.100
Biomarker
disease
BEFREE
Subretinal delivery of AAV2-mediated human erythropoietin gene is protective and safe in experimental diabetic retinopathy .
24508793
2014
×
Entrez Id:
2056
Gene Symbol:
EPO
EPO
0.100
GeneticVariation
disease
BEFREE
Identifying EPO genetic markers for high risk of developing DR could lead to the possibility of developing novel treatments or preventive therapies.
20065225
2010
×
Entrez Id:
2056
Gene Symbol:
EPO
EPO
0.100
Biomarker
disease
LHGDN
Promoter polymorphism of the erythropoietin gene in severe diabetic eye and kidney complications.
18458324
2008
×
Entrez Id:
2056
Gene Symbol:
EPO
EPO
0.100
AlteredExpression
disease
BEFREE
Erythropoietin mRNA expression was measured by quantitative real-time RT-PCR analysis in the retina from eight nondiabetic and eight age-matched diabetic donors without diabetic retinopathy
16936148
2006
×
Entrez Id:
2056
Gene Symbol:
EPO
EPO
0.100
Biomarker
disease
LHGDN
Erythropoietin is highly elevated in vitreous fluid of patients with proliferative diabetic retinopathy.
16123502
2005